Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

[1] Li G(2020)Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat Rev Drug Discovery 19 149-150

[2] De Clercq E(2004)In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds J Clin Virol 31 69-75

[3] Chen F(2020)Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Nat Commun 11 222-273

[4] Chan KH(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-236

[5] Jiang Y(2020)Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Emerg Microb Infect 9 221-1767

[6] Sheahan TP(2003)Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs Science 300 1763-1779

[7] Sims AC(2020)Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: a virtual screening and molecular modeling study Marine Drugs 59 1769-621

[8] Leist SR(2020)Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease Science 245 616-256

[9] Zhou P(2020)Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach J Biomol Struct Dyn 59 252-60

[10] Yang XL(2020)Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? atomistic insights into the inhibitory mechanisms Biochemistry 178 104786-24986

[1] Li G(2020)Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat Rev Drug Discovery 19 149-150

[2] De Clercq E(2004)In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds J Clin Virol 31 69-75

[3] Chen F(2020)Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Nat Commun 11 222-273

[4] Chan KH(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-236

[5] Jiang Y(2020)Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Emerg Microb Infect 9 221-1767

[6] Sheahan TP(2003)Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs Science 300 1763-1779

[7] Sims AC(2020)Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: a virtual screening and molecular modeling study Marine Drugs 59 1769-621

[8] Leist SR(2020)Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease Science 245 616-256

[9] Zhou P(2020)Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach J Biomol Struct Dyn 59 252-60

[10] Yang XL(2020)Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? atomistic insights into the inhibitory mechanisms Biochemistry 178 104786-24986